Form 4 for CYTK CYTOKINETICS INC
Accepted 2024-11-26 00:00:00 ET · period of report 2024-11-25 · accession 0001127602-24-028124 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-11-26 | 2024-11-25 | CYTK | WIERENGA WENDALL | Dir | M - OptEx | $7.37 | +742 | 25.3K | +3% | +$5,469 |
| D | 2024-11-26 | 2024-11-25 | CYTK | WIERENGA WENDALL | Dir | S - Sale+OE | $50.00 | -742 | 24.6K | -3% | -$37.1K |
| D | 2024-11-26 | 2024-11-25 | CYTK | WIERENGA WENDALL | Dir | M - OptEx | $0.00 | -742 | 742 | -50% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-11-25 | M | A | 742 | $7.37 | 25,301 | D | — | — | |
| 2 | Common | Common Stock | 2024-11-25 | S | D | 742 | $50.00 | 24,559 | D | — | — | |
| 3 | Derivative | Non-Qualified Stock Option (Right to Buy) | 2024-11-25 | M | D | 742 | $0.00 | 742 | D | $7.37 · 2015-02-02 to 2025-01-02 | 742 Common Stock | (F1) This option shall vest and become exercisable as to 5,936 shares divided into equal monthly installments such that the option shall be 100% vested on January 2, 2016. |